Selectivity and potency of cyclin-dependent kinase inhibitors
β Scribed by Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
- Book ID
- 111953744
- Publisher
- American Association of Pharmaceutical Scientists
- Year
- 2006
- Tongue
- English
- Weight
- 366 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1550-7416
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent research has yielded a dramatic increase in the number of connections between oncogenesis and the proteins which regulate the cell cycle. Three classes of protein which inhibit the activity of cyclin-dependent kinases (CDKs) have emerged as potential targets for oncogenic inactivation. p16 an
## Abstract Cyclin dependent kinases (Cdks) are essential enzymes for the control of cell cycle progression. Inhibitors of cyclinβdependent kinases are anticipated to possess therapeutic utility against a wide variety of proliferative diseases, especially cancer. The field of published small molecu
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
## Abstract For Abstract see ChemInform Abstract in Full Text.